Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn’s colitis: preliminary phase IB/IIA study

Journal Article Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn's colitis: preliminary phase IB/IIA study Get access Amy L Lightner, Amy L Lightner Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA Correspondence to: Amy Lightner, Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA (e-mail: lightna@ccf.org) https://orcid.org/0000-0002-0459-0699 Search for other works by this author on: Oxford Academic Google Scholar Justin Ream, Justin Ream Department of Radiology, Imaging Institute, Cleveland Clinic, Ohio, USA Search for other works by this author on: Oxford Academic Google Scholar Douglas Nachand, Douglas Nachand Department of Radiology, Imaging Institute, Cleveland Clinic, Ohio, USA Search for other works by this author on: Oxford Academic Google Scholar Clifton Fulmer, Clifton Fulmer Department of Pathology, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA Search for other works by this author on: Oxford Academic Google Scholar Miguel Regueiro, Miguel Regueiro Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA https://orcid.org/0000-0002-7681-8111 Search for other works by this author on: Oxford Academic Google Scholar Scott R Steele Scott R Steele Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA Search for other works by this author on: Oxford Academic Google Scholar British Journal of Surgery, Volume 109, Issue 8, August 2022, Pages 653–655, https://doi.org/10.1093/bjs/znac078 Published: 17 June 2022 Article history Received: 03 December 2021 Revision received: 26 January 2022 Accepted: 19 February 2022 Published: 17 June 2022